DCN is a clinical department that seeks to integrate high class clinical care with research. We straddle the University of Edinburgh and teaching hospitals (Royal Infirmary of Edinburgh and Western General Hospital) campus and combine patient driven research, large-scale international trials and laboratory research around five main areas; Stroke, Prion disease, Brain Imaging, Neuro-oncology and Regenerative Neurology (focussed on multiple sclerosis and motor neurone disease).
DCN is a division within the Centre for Clinical Brain Sciences.
 |
 |
 |
 |
||
 |
||
Professor Peter Sandercock was the 2010 recipient of the Chancellor's Award (Research category) in recognition of his research into treatments for acute stroke. The award was presented by HRH Prince Philip, Duke of Edinburgh and Chancellor of The University of Edinburgh at The Palace of Holyroodhouse.
Professor Sandercock's work in the Stroke field includes a major role in several successful international clinical trials, delivering acute stroke care and being Co-ordinating Editor of the Cochrane Stroke Group since 1998. His career grant funding totals more than £36 million. He was the inaugural head of the University's Centre for Clinical Brain Sciences, and now heads the 550 member Edinburgh Neuroscience. He has helped co-ordinate recent major initiatives in Multiple Sclerosis and Motor Neurone Disease.